ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference
03 févr. 2022 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
ProPhase Labs to Present at Two Upcoming August Conferences
16 août 2021 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that Chairman and CEO Ted Karkus is scheduled to...
ProPhase Labs to Host Second Quarter 2021 Financial Results Conference Call on Friday, August 13, 2021 at 11:00 a.m. Eastern Time
09 août 2021 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY , Aug. 09, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Friday, August 13, 2021...
Fuisz Pharma Announces Receipt of a Notice of Patent Allowance for Breath Diagnostics; The Invention addresses the Issue of Ambient Contaminants that Skew Results
22 juin 2021 08h00 HE
|
FUISZ LLC
Franklin, TN, June 22, 2021 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC (Fuisz Pharma) today announced its receipt from the United States Patent and Trademark Office (PTO) of a notice of allowance for App....
ProPhase Labs to Present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at 2:30 p.m. Eastern Time
10 nov. 2020 08h30 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, PA , Nov. 10, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase Labs”), a diversified medical science and technology company, today announced that management will...
ProPhase Labs Engages Industry Expert to Advise on Possible Acquisition of CLIA Accredited Labs Certified for COVID-19 and Other Testing
30 sept. 2020 17h04 HE
|
ProPhase Labs, Inc.
Company Enters into Consulting Agreement and Amended and Restated Promissory Note and Security Agreement with Predictive Laboratories, Inc. to Further These Plans DOYLESTOWN, Pennsylvania, Sept. 30,...
Hygea and Admera Health, a CLIA Certified/CAP Accredited Laboratory, Announce Formal Partnership
26 mai 2020 09h13 HE
|
Admera Health, LLC
SAN FRANCISCO and SOUTH PLAINFIELD, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- Hygea Precision Medicine (Hygea), a company focused on developing a precision medicine software system for healthcare...
Interpace Diagnostics Labs Receive College of American Pathology (CAP) Accreditation
25 avr. 2019 06h55 HE
|
Interpace Diagnostics Group, Inc.
Pennsylvania and Connecticut Labs Both Receive Accreditation PARSIPPANY, NJ, April 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has...
AroCell inleder samarbete med Corgenix och erbjuder analys av Tymidinkinas 1 med hjälp av AroCell TK 210 ELISA i USA
15 avr. 2019 02h00 HE
|
AroCell AB
AroCell AB (AROC NASDAQ Stockholm) tillkännager idag, i ett samarbete med Corgenix (Corgenix Inc., Colorado USA) att AroCell TK 210 ELISA-kit har validerats och godkänts för Tymidinkinas 1 (TK1)...
AroCell and Corgenix establish the measurement of Thymidine Kinase 1 using AroCell TK 210 ELISA in a CLIA-lab in the USA
15 avr. 2019 02h00 HE
|
AroCell AB
AroCell AB (AROC NASDAQ Stockholm) announce today, in collaboration with Corgenix (Corgenix Inc., Colorado USA) that the AroCell TK 210 ELISA kit has been validated and approved for Thymidine Kinase 1...